Journal
DRUG DEVELOPMENT RESEARCH
Volume 73, Issue 8, Pages 535-546Publisher
WILEY
DOI: 10.1002/ddr.21047
Keywords
metabolomics; drug discovery
Categories
Ask authors/readers for more resources
Metabolomics technology has been part of pharmaceutical discovery and development for over a decade and a half. Like many new technologies embraced by the industry, metabolomics gained early and wide acceptance as a novel tool for the rapid elucidation of mechanisms and biomarkers in preclinical discovery only to fall victim to overhype and overpromise. While many dedicated metabolomic groups have disappeared from industry, the academic world has embraced the technology and important new advances have been made such that the technology is beginning to reemerge in the industrial setting. Advances in instrumentation and data analyses have led the way in this resurgence followed by important new clinical applications. The technology has come a long way in the last decade, and we can anticipate an even more exciting ride in the next. Drug Dev Res 73 : 535-546, 2012. (C) 2012 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available